Christopher Haqq
CIK: 0001612095
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Elicio Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jul 16, 2026ELTX
Elicio Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
64.6K shares- - Feb 2, 2026ELTX
Elicio Therapeutics, Inc.
Award(A)Direct25.4K shares- - Feb 3, 2025ELTX
Elicio Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
44K shares- - Sep 30, 2024ELTX
Elicio Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
28.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 16, 2026 | ELTX Elicio Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 64,643 | - | - | Direct |
| Feb 2, 2026 | ELTX Elicio Therapeutics, Inc. | Award(A) | 25,400 | - | $0 | Direct |
| Feb 3, 2025 | ELTX Elicio Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 44,000 | - | - | Direct |
| Sep 30, 2024 | ELTX Elicio Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 28,200 | - | - | Direct |
1-4 of 4 transactions
About Haqq Christopher
Haqq Christopher (SEC CIK 0001612095) files insider reports with the SEC as Officer of Elicio Therapeutics, Inc. (ELTX).
Signal8 holds 4 ownership filings by Haqq Christopher, all Form 4s, filed between Oct 2, 2024 and Jul 17, 2026. Those filings report 4 transactions, from Sep 30, 2024 to Jul 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Haqq Christopher's filings is in BOSTON, MA.
Recent filings by Haqq Christopher
Other insiders filing for Elicio Therapeutics, Inc. (ELTX)
- ADAMS JULIAN, Director
- Ashe Carol Gail, Director
- Chudnovsky Yekaterina, Director
- Nissenson Allen, Director
- RUFFOLO ROBERT R, Director
- WILSON KAREN J, Director